~~<i id='2C6D88AC60'><strike id='2C6D88AC60'><tt id='2C6D88AC60'><pre id='2C6D88AC60'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：Wikipedia 2025-09-28 02:33:10 - browse：88391

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Male and female sex labels in research insufficient, scientists say

focus

knowledge

focus

explore

leisure time

knowledge

SammyKimballforSTATWhydoCEOstalklikethat?Dobiotechstocktipsmakegoodgifts?AndwhatdoAnthonyFauciandSté

WSS

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

UCLA team creates talking throat patch for voice disorders

New safety details link Apellis eye drug to rare cases of blindness

UCLA team creates talking throat patch for voice disorders

Breakthrough Alzheimer’s drugs are inaccessible in rural states

How many hemophilia patients actually want gene therapy?

focus

leisure time

focus

Activists slam private health insurers over coverage restrictions

Readout Newsletter: CAR

Virginia high school admissions case could be legal follow

Micronoma's microbiome cancer diagnostic approach under fire

In age of alternative facts, a scholarly course on calling out crap

Steward Health Care Massachusetts hospitals face fiscal disaster

Bright Health sells Medicare Advantage business to Molina

RaDonda Vaught links Vanderbilt hospital issues to patient death

Supreme Court strikes down use of affirmative action

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

knowledge

HHS secretary Becerra pressed on Change HealthCare cyberattack

Physician groups backed by private equity giant lobby on mergers

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Change Healthcare outage fallout shows need for new oversight

Amid AI frenzy, a top HHS official's quest to create safeguards

No plane should take off without an EpiPen onboard

focus

explore

leisure time

knowledge